Drug Sales Trends for PHISOHEX

Annual Sales Revenues and Units Sold for PHISOHEX

These sales figures are drawn from a US national survey of drug expenditures

Drug Name	Revenues (USD)	Units	Year
PHISOHEX			2021
PHISOHEX			2020
PHISOHEX			2019
PHISOHEX			2018

Market Analysis and Sales Projections for PHISOHEX

Introduction to PHISOHEX

PHISOHEX, a brand name for the active ingredient hexachlorophene, is a bacteriostatic cleansing agent used primarily as a surgical scrub and a bacteriostatic skin cleanser. It is effective against staphylococci and other gram-positive bacteria, making it a valuable tool in infection control[4].

Market Context

The market for antiseptic and germicidal products is diverse and competitive, with various alternatives available such as chlorhexidine topical and Hibiclens. However, PHISOHEX has a unique position due to its specific bacteriostatic properties and long-standing use in medical settings.

Current Market Size and Trends

While specific market size data for PHISOHEX alone is not readily available, the broader market for antiseptic and germicidal products is significant. The demand for these products is driven by the need for effective infection control measures in healthcare settings. The global antiseptics market is influenced by factors such as the increasing incidence of infections, the rise in surgical procedures, and the growing awareness of hygiene practices[4].

Competitive Landscape

PHISOHEX competes with other antiseptic agents like chlorhexidine topical and Hibiclens. Here is a brief comparison:

• Chlorhexidine Topical: Known for its broad-spectrum antimicrobial activity, chlorhexidine is widely used but has a higher incidence of side effects compared to PHISOHEX[1].
• Hibiclens: Another chlorhexidine-based product, Hibiclens has mixed reviews and a higher rate of negative side effects reported by users[1].

Sales Projections

Given the lack of specific sales data for PHISOHEX, we can infer potential sales trends from the broader antiseptics market and the product's unique selling points.

• Stable Demand: PHISOHEX is likely to maintain a stable demand due to its established use in surgical and infection control settings.
• Growth Opportunities: The increasing need for effective infection control measures, especially in hospitals and healthcare facilities, could drive growth in sales.
• Competition Impact: The presence of competitors like chlorhexidine and Hibiclens may impact sales, but PHISOHEX's specific advantages, such as its cumulative antibacterial action with repeated use, could help it retain market share[4].

User Feedback and Ratings

User reviews and ratings can provide insights into the product's performance and potential sales. PHISOHEX has an average rating of 10.0 out of 10 from a total of 2 ratings, with 100% of reviewers reporting a positive effect. This high satisfaction rate could contribute to positive word-of-mouth and repeat purchases[1].

Clinical Use and Indications

PHISOHEX is indicated for use as a surgical scrub and a bacteriostatic skin cleanser. It is particularly useful in controlling outbreaks of gram-positive infections where other measures have been unsuccessful. This specific indication can drive sales in healthcare settings where such infections are a concern[4].

Geriatric Use and Broader Demographics

Clinical studies have not identified significant differences in response between elderly and younger patients, although caution is advised due to the higher frequency of dermatological and other diseases in the elderly. This broad applicability across different age groups can help maintain a steady market demand[4].

Regulatory and Safety Considerations

The use of PHISOHEX must be cautious, especially considering its potential for absorption through intact skin and the resulting detectable blood levels. Regulatory compliance and safety precautions are crucial for maintaining market trust and avoiding adverse reactions[4].

Market Outlook and Future Prospects

The antiseptics market, including products like PHISOHEX, is expected to grow driven by increasing healthcare needs and the importance of infection control. Here are some key points:

• Growing Healthcare Needs: The expanding geriatric population and the rise in surgical procedures will continue to drive the demand for antiseptic products.
• Technological Advancements: Innovations in antiseptic formulations and delivery methods could enhance the market position of PHISOHEX.
• Comprehensive Patient Management: Integrated approaches to patient care, including the use of antiseptics like PHISOHEX, will remain critical in healthcare settings[3].

Key Takeaways

• Stable Demand: PHISOHEX is likely to maintain a stable demand due to its established use in surgical and infection control settings.
• Competitive Advantage: Its cumulative antibacterial action and high user satisfaction rates are key selling points.
• Growth Opportunities: The increasing need for effective infection control measures and technological advancements could drive growth.
• Regulatory Compliance: Ensuring safety and regulatory compliance is crucial for market success.

Frequently Asked Questions (FAQs)

1. What is PHISOHEX used for? PHISOHEX is used as a surgical scrub and a bacteriostatic skin cleanser, particularly effective against staphylococci and other gram-positive bacteria[4].

2. How does PHISOHEX compare to other antiseptics? PHISOHEX has a higher user satisfaction rate compared to some competitors like chlorhexidine topical and Hibiclens, although it faces competition in the broader antiseptics market[1].

3. What are the potential side effects of PHISOHEX? While PHISOHEX has a good safety profile, it can be absorbed through intact skin, leading to detectable blood levels. Caution is advised, especially in elderly patients or those with certain health conditions[4].

4. Is PHISOHEX suitable for all age groups? PHISOHEX can be used across various age groups, although caution is recommended for elderly patients due to potential health complications[4].

5. What are the future prospects for PHISOHEX in the market? The market for PHISOHEX is expected to grow driven by increasing healthcare needs, technological advancements, and the importance of infection control in healthcare settings[3].

Sources:

1. Drugs.com - PHisoHex Alternatives Compared
2. Stockanalysis.com - Phio Pharmaceuticals Corp. (PHIO) Stock Forecast & Price Targets
3. Biospace.com - Pulmonary Arterial Hypertension Drugs Market Size to Reach USD 11.6 Billion by 2032
4. Drugs.com - Phisohex: Package Insert / Prescribing Information
5. Tipranks.com - Phio Pharmaceuticals (44R3) Stock Forecast & Price Target